99 related articles for article (PubMed ID: 7741403)
21. Serum erythropoietin and creatinine concentrations as predictive factors for response to recombinant human erythropoietin treatment in anaemic tumour patients on chemotherapy.
Fjornes T; Wiedemann GJ; Sack K; Jelkmann W
Oncol Rep; 1998; 5(1):81-6. PubMed ID: 9458299
[TBL] [Abstract][Full Text] [Related]
22. [Determination of the standard level of serum erythropoietin in relation to hemoglobin concentration].
Takahashi Y; Yoshida Y; Hara H; Yamaguchi N; Kawagoe H; Shibata H; Teshima H; Ohno Y; Akasaka K
Rinsho Ketsueki; 1993 Apr; 34(4):465-72. PubMed ID: 8510335
[TBL] [Abstract][Full Text] [Related]
23. Serum erythropoietin level and marrow erythroid infiltration predict response to recombinant human erythropoietin in myelodysplastic syndromes.
Depaoli L; Levis A; Isabella N; Ficara F; Priotto C; Lista P; Foà R; Resegotti L
Haematologica; 1993; 78(2):118-22. PubMed ID: 8349187
[TBL] [Abstract][Full Text] [Related]
24. [Erythropoietin in sideropenic anemias].
Pavlović-Kentera V; Biljanović-Paunović L; Ruvidić R; Milenković P
Bilt Hematol Transfuz; 1978; 6(1):5-11. PubMed ID: 755483
[TBL] [Abstract][Full Text] [Related]
25. Low serum levels of tumor necrosis factor and interleukin-1 beta in myelodysplastic syndromes responsive to recombinant erythropoietin.
Musto P; Matera R; Minervini MM; Checchia-de Ambrosio C; Bodenizza C; Falcone A; Carotenuto M
Haematologica; 1994; 79(3):265-8. PubMed ID: 7926977
[TBL] [Abstract][Full Text] [Related]
26. Functional erythropoietin deficiency in patients with Type 2 diabetes and anaemia.
Thomas MC; Tsalamandris C; Macisaac R; Jerums G
Diabet Med; 2006 May; 23(5):502-9. PubMed ID: 16681558
[TBL] [Abstract][Full Text] [Related]
27. [Erythropoietin in non-specific intestinal inflammation].
Hertlová M; Zboril V; Kautská J; Pokorný A; Prokopová L
Vnitr Lek; 1998 Aug; 44(8):451-5. PubMed ID: 10358447
[TBL] [Abstract][Full Text] [Related]
28. Mineral metabolism and haemoglobin concentration among haemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Kimata N; Akiba T; Pisoni RL; Albert JM; Satayathum S; Cruz JM; Akizawa T; Andreucci VE; Young EW; Port FK
Nephrol Dial Transplant; 2005 May; 20(5):927-35. PubMed ID: 15728270
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: results of a randomized, double-blind, placebo-controlled trial.
Vincent JL; Spapen HD; Creteur J; Piagnerelli M; Hubloue I; Diltoer M; Roman A; Stevens E; Vercammen E; Beaver JS
Crit Care Med; 2006 Jun; 34(6):1661-7. PubMed ID: 16607233
[TBL] [Abstract][Full Text] [Related]
30. Assessing erythropoiesis and the effect of erythropoietin therapy in renal disease by reticulocyte counting.
Pradella M; Cavill I; d'Onofrio G
Clin Lab Haematol; 1996 Dec; 18 Suppl 1():35-7. PubMed ID: 9054717
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation of treatment of anemia with erythropoietin in patients with multiple myeloma].
Adam Z; Krahulová M; Spelda S; Vorlícek J; Hejlová N; Hájek R; Tomíska M
Vnitr Lek; 1995 Nov; 41(11):767-72. PubMed ID: 8553596
[TBL] [Abstract][Full Text] [Related]
32. Serum immunoreactive erythropoietin during the perioperative period.
Clemens J; Spivak JL
Surgery; 1994 Apr; 115(4):510-5. PubMed ID: 8165543
[TBL] [Abstract][Full Text] [Related]
33. Standard clinical practice underestimates the role and significance of erythropoietin deficiency in sickle cell disease.
Saraf S; Farooqui M; Infusino G; Oza B; Sidhwani S; Gowhari M; Vara S; Gao W; Krauz L; Lavelle D; DeSimone J; Molokie R; Saunthararajah Y
Br J Haematol; 2011 May; 153(3):386-92. PubMed ID: 21418176
[TBL] [Abstract][Full Text] [Related]
34. Serum erythropoietin and erythropoiesis in patients with myelodysplastic syndromes.
Bowen DT; Jacobs A; Cotes PM; Lewis TC
Eur J Haematol; 1990 Jan; 44(1):30-2. PubMed ID: 2307217
[TBL] [Abstract][Full Text] [Related]
35. Serum erythropoietin levels after renal transplantation with various graft outcomes.
Ghods AJ; Arghani H; Ghadiri G
Transplant Proc; 1995 Oct; 27(5):2577-8. PubMed ID: 7482834
[No Abstract] [Full Text] [Related]
36. The treatment of anaemia in the myelodysplastic syndromes with recombinant human erythropoietin.
Bowen D; Culligan D; Jacobs A
Br J Haematol; 1991 Mar; 77(3):419-23. PubMed ID: 2012769
[TBL] [Abstract][Full Text] [Related]
37. Erythropoietin Levels in Elderly Patients with Anemia of Unknown Etiology.
Gowanlock Z; Sriram S; Martin A; Xenocostas A; Lazo-Langner A
PLoS One; 2016; 11(6):e0157279. PubMed ID: 27310832
[TBL] [Abstract][Full Text] [Related]
38. Decreased erythropoietin response in Plasmodium falciparum malaria-associated anaemia.
el Hassan AM; Saeed AM; Fandrey J; Jelkmann W
Eur J Haematol; 1997 Nov; 59(5):299-304. PubMed ID: 9414641
[TBL] [Abstract][Full Text] [Related]
39. Defective erythropoietin production and reticulocyte response in acute Plasmodium falciparum malaria-associated anemia.
Leowattana W; Krudsood S; Tangpukdee N; Brittenham G; Looareesuwan S
Southeast Asian J Trop Med Public Health; 2008 Jul; 39(4):581-8. PubMed ID: 19058593
[TBL] [Abstract][Full Text] [Related]
40. Erythropoietin response to anaemia in children with sickle cell disease and Fanconi's hypoproliferative anaemia.
McGonigle RJ; Ohene-Frempong K; Lewy JE; Fisher JW
Acta Haematol; 1985; 74(1):6-9. PubMed ID: 3934912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
